The amount of bone generated using current tissue engineering approaches is insufficient for many clinical applications. Previous in vitro studies suggest that culturing cells as 3D aggregates can enhance their osteogenic potential, but the effect on bone formation in vivo is unknown. Here, we use agarose wells to generate uniformly sized mesenchymal stromal cell (MSC) aggregates. When combined with calcium phosphate ceramic particles and a gel prepared from human platelet-rich plasma, we generated a tissue engineered construct that significantly improved in vivo bone forming capacity as compared to the conventional system of using single cells seeded directly on the ceramic surface. Histology demonstrated the reproducibility of this system, which was tested using cells from four different donors. In vitro studies established that MSC aggregation results in an up-regulation of osteogenic transcripts. And finally, the in vivo performance of the constructs was significantly diminished when unaggregated cells were used, indicating that cell aggregation is a potent trigger of in vivo bone formation by MSCs. Cell aggregation could thus be used to improve bone tissue engineering strategies.
Introduction
Numerous animal studies and clinical trials have been performed to optimise the use of mesenchymal stromal cells (MSCs) for bone tissue engineering, with both revealing that the degree of bone formation is frequently inadequate (Chatterjea et al., 2010; Griffin et al., 2011; Meijer et al., 2008) . One challenge is that while MSCs can be easily isolated from a variety of adult tissues and differentiated into multiple adult cell types including bone cells, their low frequency and limited propensity for osteogenic differentiation often necessitates in vitro expansion and pre-differentiation (Bruder et al., 1998; Friedenstein et al., 1966) . Taken together, these limitations establish the importance of developing conditions that can improve both the bone forming capacity of MSCs and reduce the need for in vitro expansion.
Within the developing limb, condensation of MSCs triggers the process of differentiation, favouring chondrogenesis and osteogenesis (Hall and Miyake, 2000) . For tissue engineering applications, it is thought that the aggregation of MSCs could initiate that same developmental programme (Achilli et al., 2012; Fennema et al., 2013) . MSC aggregation has been shown to improve their differentiation capacity (Wang et al., 2009) , particularly as a model for chondrogenic differentiation and cartilage tissue engineering (Ravindran et al., 2011; Steck et al., 2005) , and to generate a cartilage template for bone formation (Jukes et al., 2008; Rivron et al., 2012; Scotti et al., 2010) . Fewer studies have explored MSC aggregation for osteogenic differentiation. An early study showed that aggregated rat cells had a higher degree of alkaline phosphatase expression, an important bone marker, than those cultured in a monolayer on tissue culture plastic (Gerber and ap Gwynn, 2002) . Additional studies have demonstrated the positive effect of MSC aggregation on gene and protein expression related to bone formation in vitro (Kale et al., 2000) , but definitive studies revealing an advantage in vivo are lacking.
The present study thus aims to establish the importance of cell aggregation on osteogenic differentiation of MSCs in vitro and in vivo by directly comparing both aggregated and unaggregated MSCs combined with ceramic particles A Chatterjea et al. Improved bone formation by aggregated MSCs and a platelet-rich plasma (PRP) gel. The growth factors from the platelet-rich plasma, which can be used in a clinical setting, have been shown to positively affect the proliferation of MSCs (Lucarelli et al., 2003) and are thought to play a role in their osteogenic differentiation (Intini, 2009) . When combined with biomaterials and cells, platelet-rich plasma has also been shown to promote bone formation in heterotopic sites (Bi et al., 2010; Kasten et al., 2008; Yamada et al., 2004) . Studies to determine the time required to culture the MSCs as aggregates in order to optimise the amount of bone formed in vivo are performed so as to make the system more clinically feasible. The PRP construct also was compared to a conventional bone tissue engineering construct, in which cells are seeded directly on the ceramic scaffold, to demonstrate the advantage offered by MSC aggregation.
Materials and methods

Cell culture
Human mesenchymal stromal cells (MSCs) were either obtained from bone marrow aspirates or commercially (Lonza) as cryopreserved cells. Bone marrow aspirates of 5-20 mL were obtained from healthy donors (male and female, ages 53-72) during hip replacement surgery with written informed consent. Upon isolation, the cells were resuspended using a 20G needle, and plated at a density of 50,000 mononuclear cells/cm 2 . MSCs were expanded in α-minimal essential medium (α-MEM, Life Technologies) supplemented with 10 % (v/v) foetal bovine serum (FBS, Cambrex), 0.2 mM ascorbic acid, 2 mM l-glutamine, 100 U/mL penicillin, 10 µg/mL streptomycin, and 1 ng/ mL basic fibroblast growth factor (Instruchemie). Cells were cultured at 37 °C in a humid atmosphere with 5 % CO 2 . Medium was refreshed twice weekly and prior to confluence, cells were trypsinised and cryopreserved until needed.
Generation of cell aggregates
MSC aggregates were formed by seeding cells within agarose microwells (Rivron et al., 2012) . First, a polydimethylsiloxane (PDMS) stamp of the inverse of 1400 circular wells (each 400 µm in diameter and height) was produced from a silicon wafer using standard lithographic techniques (Xia et al., 1996) . Following sterilisation in 70 % ethanol, the PDMS stamp was covered with 3 % (w/v) ultra pure agarose (Invitrogen). Upon solidification, the agarose templates were de-moulded and transferred to a non-adherent 12-well tissue culture plate. After wetting the agarose microwell templates with cell culture medium, 1.5 million cells concentrated in 1 mL of medium (unless otherwise stated) were uniformly dispersed over the wells. Following a brief centrifugation at 1500 rpm to facilitate entering the wells, the cells were cultured for 24 h in differentiation medium [Dulbecco's Modified Eagle Medium supplemented with 0.1 µM dexamethasone, 50 µg/mL ascorbic acid, 40 µg/mL proline, 100 µg/mL sodium pyruvate, and 50 mg/mL ITS 1 Premix (Becton-Dickinson)], during which they spontaneously formed aggregates.
Platelet-rich plasma isolation
To obtain platelets, a standard thrombocyte apheresis procedure was performed on healthy donors using a Cobe Spectra/Trima apheresis unit following written consent. Thereafter, the platelets from a single donor were preserved at −80 °C. At the time of the experiment, the platelets from several donors were pooled, lysed at 37 °C, and 235 µL of 1 M calcium chloride was added per 10 mL of lysate for 10 min at 37 °C on a roller shaker. The resulting solution was separated into a clear liquid (thrombin source) and a gel-like platelet lysate component (fibrinogen source).
Platelet-rich plasma (PRP) constructs
Platelet-rich plasma (PRP) constructs were prepared by combining the aggregated MSCs and particles of a calcium phosphate ceramic into the PRP gel (Fig. 1a) . Biphasic calcium phosphate (BCP) ceramic particles were produced according to the H 2 O 2 method including naphthalene at a sintering temperature of 1150 °C for a particle size of 53-63 μm (Yuan et al., 2002) . MSC aggregates, which had been cultured for 24 h in the agarose microwells, were flushed from the wells with medium and transferred to a 10 mL conical tube containing 25 mg of BCP particles. Following a brief centrifugation, 300 μL of the prepared thrombin solution was added to the cell aggregate and BCP particle mixture, followed by 300 μL of platelet lysate. The contents of the tube were transferred to a non-adherent 25-well plate that had been pre-warmed to 37 °C, where a PRP gel encapsulated the MSC aggregates and BCP particles in 10-12 s. The PRP constructs were thereafter maintained in differentiation medium at 37 °C for two weeks prior to implantation, unless indicated otherwise. To isolate the effects of the aggregation of MSCs, 1.5 million unaggregated cells were alternatively added to the BCP particles and incorporated in a PRP gel using the aforementioned strategy (Fig. 1b) .
Cell-ceramic constructs
To compare the PRP construct to a more commonly used tissue engineering approach, cell-ceramic constructs without the PRP gel were prepared (Fig. 1c) . A suspension of 600,000 MSCs was seeded on three 1-2 mm BCP particles. For comparison, PRP constructs were also prepared with 600,000 instead of 1.5 × 10 6 cells. The cellceramic construct was cultured for two weeks in α-MEM supplemented with 10 % (v/v) FBS, 0.2 mM ascorbic
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Commercially bought (SABiosciences) acid, 2 mM l-glutamine, and 10 μM dexamethasone prior to implantation.
Cell quantification
For cell quantification, constructs were transferred to a tube containing CyQUANT (Molecular Probes) cell lysis buffer and were frozen at −80 °C. After 24 h, the contents of the tubes were thawed to ambient temperature and sonicated to release the DNA into the supernatant. Total DNA was quantified with a CyQUANT DNA kit on a fluorescence plate reader (Perkin-Elmer Victor 3), and compared to a standard curve.
Gene expression analysis
After 2 weeks in vitro, constructs were prepared for gene expression analysis. They were washed with PBS, lysed in Trizol reagent (Invitrogen) for 5 min, and stored at −80 °C until RNA isolation. RNA was isolated using a NucleoSpin RNA II kit (Machery-Nagel), and was assessed on a NanoDrop 1000. First strand cDNA was synthesised using iScript (BioRad). Real-time qPCR was performed on 1 µL cDNA, on a LightCycler (Roche) for a panel of osteogenic genes. Relative gene expression was calculated using the ΔΔCt method, with B2M (beta-2-microglobulin) as a housekeeping gene. Primer sequences are listed in Table 1 .
In vivo studies
All in vivo experiments were approved by the local animal experimental committee. Constructs were implanted ectopically in immunodeficient mice, a widely used model for assessing the bone forming capacity of MSCs (Scott et al., 2012) . Ten immune deficient male mice (Hsd-cpb: NMRI-nu, Harlan Laboratories) were used for each of the experiments except in the time course study, when six animals were sacrificed at each of the three time points (2, 4 and 8 weeks). The mice were observed for healthy behaviour following surgery and were anaesthetised by inhalation of isoflurane and carbon dioxide. Four subcutaneous pockets were made on the dorsal aspect of each mouse for implantation (one construct of approximately 6 mm diameter per pocket), after which the incisions were closed using a vicryl suture. To explant the samples, the mice were sacrificed using carbon monoxide.
Bone histology and quantification
To quantify bone formation, the explanted samples were fixed in 4 % (w/v) paraformaldehyde and embedded in methacrylate for sectioning. Sections (approximately 10 μm-thick) were prepared with a histological diamond saw (Leica microtome), and stained with basic fuchsin and methylene blue to visualise bone formation. The newly formed mineralised bone stained red with basic fuchsin, the unmineralised osteoid stained light pink, other cellular tissues stained light blue with methylene blue, and the ceramic material remained unstained by both dyes. Histological sections were qualitatively analysed by light microscopy (Nikon E600), and scored either positive or negative for bone formation. In addition, quantitative histomorphometry was performed. Briefly, high-resolution digital photographs were made of three sections. The bone and the ceramic material were manually pseudo-coloured using Adobe Photoshop CS2, and a custom-made Matlab (MathWorks) script was used to measure the bone/ceramic surface ratios, which were averaged from three randomly selected, non-continuous sections per sample.
Statistical analysis
Statistical analysis for the in vivo experiments was performed using ten mice (except in the time course study, where six mice were used per time point) and three sections per implant. For in vitro studies, the experiments were performed in independent triplicates. When differences between two groups were analysed, a Student's t-test was used. In studies where three or more groups were compared, results were analysed with one-way analysis of variance (ANOVA) with Tukey's post-hoc analysis. Results were considered statistically significant when p < 0.05.
Results
The PRP construct forms bone in vivo
We first sought to demonstrate that the combination of the PRP gel, ceramic particles, and aggregated cells (the "PRP construct", Fig. 1a ) could reproducibly form bone in an ectopic location in immunodeficient mice.
Ten PRP constructs were prepared from each cell source (three different primary donors and one commercial cell source). After six weeks of implantation, bone formation was observed in all constructs, with an average of 20.1 % of the total scaffold area filled with bone (Fig. 2a) . In all constructs, there were areas of mature bone aligning areas of osteoid (Fig. 2b) , and regions suggestive of bone marrow, indicating a functional bone organ (Fig. 2b-d) .
No signs of inflammation were observed.
MSCs are necessary for bone formation
It was then important to determine whether the implanted cells were, in fact, necessary for bone formation. Since the PRP gel is a storehouse for multiple growth factors (Landi et al., 2011; Yang et al., 2011) , many of which are involved in bone formation, and the ceramics alone can induce bone formation in ectopic sites (Carragee et al., 2011) , we considered that the PRP construct may be capable of recruiting cells to form bone. To test this, we compared bone formation in the PRP construct implanted both with and without cells. Following 2 weeks of culture in vitro of the constructs with cells, both types of constructs were implanted subcutaneously in ten mice. While abundant bone (average of 11.2 % bone/scaffold area) was observed 
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in the cell-laden PRP construct, no evidence of bone was observed in the constructs lacking cells (Fig. 3a , quantified in Fig. 3b ).
The PRP gel is superior to cells seeded directly on scaffolds Next, to establish the role of the PRP gel, we compared the PRP construct to a conventional tissue engineering construct, in which MSCs are seeded directly on a ceramic (the "cell-ceramic construct", Fig. 1c) . Ten of each construct were prepared with 600,000 cells from each of two donors. For the PRP construct, they were aggregated according to the above method, while in the conventional construct, cells were carefully seeded directly on the ceramic particles. After two weeks of in vitro culture, cell number was quantified. There were significantly more cells on the scaffolds in the conventional construct than the PRP construct after the 2 week culture period (Fig. 4a) . The constructs were then implanted in ten mice for 6 weeks, after which they were explanted and bone formation was quantified. The amount of bone formed was significantly greater in the PRP construct compared to the cell-ceramic construct (Fig. 4b) , increasing from 5.0 % to 22.0 % with cells from one donor and 0 % to 8.6 % from another.
Cell aggregation increases the amount of bone formed
We then sought to establish the role of cell aggregation in the PRP construct by implanting constructs with either aggregated or unaggregated cells (n = 10 mice). After six weeks of implantation, histological examination of bone formation (for a mineralised matrix with embedded osteocytes) revealed that both constructs initiated the formation of bone tissue, but the amount was significantly Fig. 3 . MSCs need to be implanted for bone formation. (a) When the PRP gel was implanted without cells, only the scaffold (sc) could be viewed, and no bone formation was detected. The difference in bone formation when constructs were implanted both with and without cells is quantified in (b). Scale: 100 μm. n = 10.
Fig. 4.
Implanting cells in the PRP construct is superior to seeding them directly on a ceramic. (a) After 2 weeks in vitro, the total number of cells was significantly diminished within the PRP construct compared to on ceramic scaffolds. (b) However, after six weeks of implantation, there was significantly more bone formation when the PRP construct was implanted compared to when cells were directly seeded on scaffolds. * signifies p < 0.05. n = 10.
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higher when MSC aggregates were used (Fig. 5a) . Specifically, the total amount of bone formed increased from 5.3 % to 29.1 % with cells from one donor, and from 7.6 % to 22.2 % with cells from a second donor in constructs with the same number of unaggregated and aggregated cells, respectively. This effect could not be attributed to differential rates of cell proliferation in the different constructs, since after two weeks of culture in vitro (n = 10 constructs with 1.5 × 10 6 cells), a cell quantification assay revealed no statistically significant difference in cell number (Fig. 5b) . It is unlikely that the large difference in bone formation came from a small difference in cell number.
Cell aggregation improves the expression of bone markers
We were also interested to see if cell aggregation could enhance the in vitro expression of genes related to osteogenic differentiation. We performed qPCR after 2 weeks in vitro and found that the osteogenic genes were generally up-regulated in aggregated cells compared to unaggregated (Fig. 5c,d) . ALPL (alkaline phosphatase) and BMP2 (bone morphogenetic protein-2) expression were up-regulated (p < 0.05) in aggregated cells from both donors, and SPP1 (osteopontin) was up-regulated in aggregated cells from one donor.
In vitro culture time is insignificant
A limitation to the clinical usefulness of tissue engineering constructs is the prolonged in vitro culture time prior to implantation. We therefore sought to test whether our system could induce bone formation even after a shortened incubation period in vitro. Ten PRP constructs were cultured in differentiation medium for 0 (i.e. implanted immediately), 1, 2 or 4 weeks prior to implantation. Following 6 weeks of in vivo implantation, the constructs were explanted and histological analysis was performed. The results indicated that bone formed irrespective of the in vitro culture time (Fig. 6a) . The average amount of bone occupying the total scaffold area was 10.4 %, 16.7 %, 20.5 %, and 8.0 % for constructs cultured for 0, 1, 2 or 4 weeks, respectively (one-way ANOVA, p > 0.05).
Mature bone begins to form after four weeks
Finally, to obtain information on the time-course of bone formation, we generated PRP constructs using aggregated cells from two donors, implanted them in nude mice, and explanted samples after 2, 4 and 8 weeks for histology. 
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After 2 weeks, we found no evidence of cartilage or mature bone although very small areas reminiscent of osteoid were observed (Fig. 6b) . Four weeks after implantation, there were areas of mature bone lined with areas of osteoid tissue (Fig. 6c) . After 8 weeks, the amount of mature bone as well as osteoid tissue was further increased (Fig. 6d ) and areas suggestive of bone marrow were also observed.
Discussion
The clinical application of MSCs in the field of bone tissue engineering is partly impaired by the suboptimal amount of bone generated using conventional methods and the variation in the ability of the isolated cells to form bone in vivo (Siddappa et al., 2007) . In this study, we describe a clinically applicable in vitro culture system that, by the simple step of cell aggregation and incorporation in a platelet-rich plasma (PRP) gel with calcium phosphate particles, programmes donor-derived MSCs to reproducibly generate significantly greater amounts of bone than that obtained by a conventional bone tissue engineering approach in which a cell suspension is seeded on the scaffold. The efficacy of this approach was exemplified when cells from one donor led to 8 % of the total scaffold area filled with bone, while they failed to generate any detectable bone with the conventional system. Cell aggregation was demonstrated to be responsible for some of the positive effects of the PRP construct, and represents a strategy to enhance the bone formation capacity of the limited number of MSCs that can be derived from bone marrow. We show that in vitro aggregation is a simple, safe and cost-effective step that thereafter improves the performance of the cells upon implantation in vivo. The beneficial effects were in accordance with the enhanced in vitro expression of osteogenic genes observed in this study, as well as that reported in a number of recent publications (Baraniak and McDevitt, 2012; Frith et al., 2010; Ma et al., 2011) . Cell aggregation is also commonly used for chondrogenic differentiation (Erickson et al., 2002; Puetzer et al., 2010; Wang et al., 2003) , in other disciplines such as cancer research, and in the pharmaceutical industry in 
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order to test the potential in vivo effects of drug therapies (Kobayashi et al., 1993; Kunz-Schughart, 2004) , but this study establishes its potential for bone tissue engineering. Another significant advantage of the approach described in this study is that the in vitro culture time of the constructs had no statistically significant effect on the amount of bone formation after six weeks of implantation. This is an improvement upon a previously reported strategy, where cell aggregates without ceramics were first matured into cartilage templates in vitro before implantation to generate bone in vivo (Scotti et al., 2010) . In that study, at least two weeks of in vitro maturation were required to ensure their retrieval at the time of explantation, a time-frame that could be unsuitable for clinical applications. In contrast, the PRP constructs in this study could be filled with a large amount of bone, even without an in vitro maturation step.
The primary cells isolated from human donors did not show any evidence of cartilage tissue, suggesting bone formed via the intramembranous ossification route. One possible explanation is that it is well known that bone formation can be modulated by environmental factors such as growth factors, oxygen concentration, or mechanical stimuli (Gawlitta et al., 2010) and, in this experiment, the cells were isolated at ambient oxygen, which has been shown to diminish their chondrogenic potential (Morita et al., 2007) . It is also likely that yet unidentified factors present both in vitro and in vivo can influence the behaviour of cells and determine the path taken by them to generate bone.
It is a reasonable reality that tissue engineered constructs containing MSCs will be available in the clinic in the near future. The optimisation of methods to isolate cells and prepare a scaffold that can reliably induce bone formation is therefore of high interest and importance. In this study, we show that patient-derived MSCs can be combined with a PRP gel derived from human plasma and calcium phosphate ceramics, and that this will form bone without the need for recombinant proteins such as growth factors, or other biomolecules. The success of the approach could be attributed to the pre-aggregation of the MSCs, a simple method that led to strikingly higher bone formation in vivo. The PRP gel itself is also an especially strong candidate for tissue engineering because it is patient-derived, chemical-free, a source of a plethora of growth factors, and can gel at a physiological temperature. Indeed, we recently demonstrated that it could be injected and gelled in situ (Chatterjea et al., 2013) , and this work shows its promise for implantable bone tissue engineering.
Conclusions
The clinical efficacy of bone tissue engineering is limited by the insufficient quantity of bone produced. By preaggregating human mesenchymal stromal cells prior to combining them with calcium phosphate ceramics and a platelet-rich plasma gel, we were able to reproducibly generate more bone tissue in nude mice and more bone markers in vitro. The aggregation was central to enhanced bone formation, and we found that the in vitro maturation period typically required prior to implantation could be eliminated. In conclusion, this study underlines the notion that MSC aggregation is a potent trigger of in vivo bone formation, a finding that could improve bone tissue engineering approaches.
